See an open-access update from Decibio on three new trends in the I/O biomarker field - online here, released March 2, 2020. They review data on trends beyond PD-L1, like gene expression profiling and NGS.
Tuesday, March 3, 2020
Very Brief Blog: Decibio updates trends in immuno-oncology biomarkers
Los Angeles-based consultancy Decibio (here) maintains and constantly updates a large database for immuno-onology (their "I/O BioMAP;" here).
See an open-access update from Decibio on three new trends in the I/O biomarker field - online here, released March 2, 2020. They review data on trends beyond PD-L1, like gene expression profiling and NGS.
See an open-access update from Decibio on three new trends in the I/O biomarker field - online here, released March 2, 2020. They review data on trends beyond PD-L1, like gene expression profiling and NGS.
